Experimental nephritis associated with plasmodium infection in mice  by Parbtani, Anwar & Cameron, J. Stewart
Kidney International, Vol. 16 (1979), pp. 53-63
Experimental nephritis associated with plasmodium
infection in mice
AN WAR PARBTANI and J. STEWART CAMERON
Renal Unit, Department of Medicine, Guy's Hospital, London, England
The association of glomerulonephritis with
plasmodial infections has been studied mostly in
man [1-5], but plasmodial infections in other spe-
cies may be associated with a glomerulonephritis
believed to result from the formation and deposition
of immune complexes. This has been studied in
rhesus monkeys [6, 7], owl monkeys [8— 11], chick-
ens [12—14], rats [15]. and mice [16—24]. In these
species, as well as the recognized effects of the
acute hemolysis on the kidney analogous to black-
water fever in man [25-27], immune-mediated gb-
merulonephritis seems to be a common sequel to
plasmodial infections.
Plasmodium berghei has as its host tropical ro-
dents [28, 29] and mice, the vector in the wild being
Anopheles stephensi. Plasmodium berghei berghei
infection is usually followed by death in untreated
animals, although the time to death varies greatly
from strain to strain [30]. Plasmodium berghei
yoelii infections, in contrast, are milder, and, in
most strains of mice, moderate inoculations kill on-
ly a minority of animals [31]. Subsequent challenge
in both treated Plasmodium berghei berghei infec-
tion and in the survivors of Plasmodium berghei
yoelii infection fails to reestablish infection [31, 32].
Several studies [16-24] (Table 1) have shown that a
glomerulonephritis, apparently dependent upon the
deposition of immune complexes in the kidney, ac-
companies the acute infection in the majority of ani-
mals of all strains of mice so far tested, whether in-
fected with Plasmodium berghei berghei or
Plasmodium berghei yoelii. In this review, we will
give an account of our own recently published [21]
and unpublished studies, and we compare these re-
sults with those obtained by other workers [16-20,
22—24].
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Methods
Initially, we studied mice of the ICI SAS strain
[21], together with a small number of mice of
TO, A2G, and LACA strains. More recently (Parbta-
ni, unpublished observations), we have used the
CD-i strain. Mice weighing between 25 and 30 g (4
to 5 weeks old) were used.
Malaria parasites were the 17x strain of Plasmo-
dium berghei yoelii, donated by Professor F. E. G.
Cox. In the ICI-SAS mice, l0 parasites were inject-
ed i.p., but in CD-i mice doses above l0 parasites
i.p. resulted in the death of all the mice. A dose of
10 parasites i.p. was used, therefore, but even this
dose gave considerable mortality (Table 1).
Antiplasmodial antibodies were measured initial-
ly as previously described [21], but more recently in
the CD-i mice studies, plasmodial antigen was pre-
pared by the method of Lunde and Powers [33], and
antiplasmodial antibodies were assessed by double
diffusion in agarose gel.
Plasma complement level was measured by radial
immunodiffusion into gel containing monospecific
antibody to mouse C3.
Plasma creatinine concentrations were measured
in blood samples obtained by cardiac puncture with
the LKB Ultralab 2086 reaction rate-dependent an-
alyzer.
Urine protein was measured by the Biuret meth-
od, and urinary albumin, by radial immunodiffusion
into agar containing a monospecific antiserum to
mouse albumin, raised in rabbits.
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Table 1. Studies on Plasmodium berghei malarial nephropathy in mice
Peak
Ref. Year Author
Strain
of mice Parasite
Weight or
age of mice
Dose of
parasite
parasitemia
% Day
Mortality
%
25 1972 ErichandVoller TO Pb. yoelii 22to27g 107i.p. 17 8 ?0
26 1972 Boonpucknavig et al Swiss albino P.b. berghei 25 to 30 g 106 i.p. 87 21 '0
28 1974 Suzuki DDY P.b. berghei 5 weeks l0 i.p. ? 8 boa, 10
29 1976 George et al ICI-SAS Pb. yoelii 20 to 30 g l0 i.p. 77 17 8
— 1977 Parbtani CD-l Pb. yoelii 25to30g l03i.p. 63 21 67
30 1977 Poels et al BALB/c Pb. berghei 10 to 20 weeks 10 i.p. 6O
?
14a
?
bOa, 15C
a Untreated mice
Suiphomonomethoxine-treated mice (days 3 to 6)
Chloroquine-treated mice (day 14)
'0
U
'4-0
St
E
C,
Co
..——.. 'Early high mortality' group
— Mean of all mice
'Late low mortality' group
Renal biopsy specimens were fixed in alcoholic mortality during the first week of infection. The var-
Bouin's solution for paraffin embedding and optical iation in the infection of the mature erythrocytes in
microscopy, in 2.5% buffered glutaraldehyde for different strains of mice is attributed, by the au-
araldite embedding and electron microscopy, and thors, to the genetic differences in the strains of
snap-frozen in liquid nitrogen for immunofluor- mice.
escent study, as previously described in detail [21]. Parasitemia. In the CD-i mice, the mean para-
Results
sitemia showed a bimodal peak on days 10 to 12 and
day 21 (Fig. 1). The mice that died before day 12
Mortality. Ninety-two CD-i mice infected i.p. ("early high mortality") and the remainder showed
with l0 parasites were observed for up to 70 days no difference in parasitemia until day 7, but then
following infection. Even with this very low dose of
parasites, 62 (67%) died before day 24. Mice heavily
parasitized (> 20%) at day 8 rarely survived the
"early mortality" peak at days 10 to 12 (Fig. 1).
This mortality is much higher than is that reported
by Ehrich and Voller [17] or our own data in ICI-
SAS mice [21] (Table 1). Mortality was equally low
in A2G mice (which produce low-affinity antibodies)
and TO mice (which produce high-affinity anti-
bodies) [34]. The timing of the mortality of CD-i
mice in our studies was similar to that observed by
Finerty and Krehl [35] in the same strain of mice
infected withPlasmodium bergheiyoelii 17XL, ale-
thal substrain of Plasmodium berghei yoelii 17X.
Suzuki [20] reported 100% mortality in untreated 20
DDY mice infected with 10 Plasmodium berghei
berghei NK65; deaths occurred between 6 and 13
days after infection. 15
This variable mortality between strains of mice
for Plasmodium berghei yoelii parallels the varia- 10
tion in time to 50% mortality from Plasmodium berg-
hei berghei (6 to 37 days) observed by Greenberg 5
and Kendrick [30]. The segregation into "early high
mortality" group and "late low mortality" group
(Fig. 1) may reflect differences in T-cell function, or 20 40 50 60 70
antibody quality. Greenberg and Kendrick [30] sug-
gest the crisis of the infection in mature erythro-
cytes followed by acute hemolysis to be a cause of
Days from malaria infection
Fig. 1. Parasitemia and mortality of CD-I mice infected with
Plasmodium berghei yoelii (1O parasites/mouse),
0 10
Days from malaria infection
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there was a rapid rise to 70% parasitemia in those
who died early. The mortality in the remaining mice
was only 27% ("late low mortality") (Fig. 1). The
biomodal mortality and parasitemia in mice infected
with Plasmodium berghei was noted by Greenberg
and Kendrick [30] and was studied also by Nadel et
al [36], and Eling and Jerusalem [37] in their study
of Swiss and C3H/St Z mice infected with Plasmo-
dium berghei yoelii. In all studies so far reported
[17—24], parasites disappear from the blood some-
where between 20 days [17] and 50 days (present
study) after infection.
Antiplasmodial antibodies were detectable on
day 5 in the present study, on day 7 in the ICI-SAS
mice [21], on day 7 in Boonpucknavig's study [18],
and on day 14 in Poel's study of BALBIC mice. In
this last study, nude mice never developed anti-
bodies (and never developed immune deposits in
their kidneys). In all studies, high titers of antibody
were still present at the last point examined, from
40 [22] to 150 [21] days after infection.
Rena/function studies. Although studies in mice
[25], hamsters [26], and rhesus monkeys [27] had
shown severe uremia in association with fulminant
malarial infections accompanied by hemolysis, se-
vere anemia, and pigment deposition in the kidneys,
previous studies of glomerulonephritis had not in-
cluded any measure of nitrogen retention. In our
study of CD-i mice (Fig. 2), the mean plasma creati-
nine of 33 uninfected mice was 0.52 0.08 (± 2 SD).
Between days 13 and 33, 35% of the infected mice
had increased creatinine concentrations, and on day
16, 4 of 6 mice tested had increased concentrations
(0.71 0.09, mean sEM). From day 34, all mice
showed normal plasma creatinine concentrations.
An interesting observation was that plasma creati-
nine concentrations were lower than was the mean
minus 2 SD, in some animals, particularly from day
5 to 13.
It is difficult to know how much of this increase in
plasma creatinine concentration relates to the acute
malarial infection and hemolysis. Certainly our ani-
mals were not severely anemic; at least the "late
low mortality" group, which included most of the
animals with raised plasma creatinine concentra-
tions, were not. Tubular changes were not found in
the kidneys, so it seems likely that the renal dys-
function noted relates mostly to the glomerular
changes found.
Protein is detectable in urine samples from nor-
mal mice [21, 38], and the great majority of samples
from the infected mice fell within normal limits
(20.0 13.8, mean 2 SD), with only ii out of 113
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Fig. 2. Renal function study of CD-i mice infected with Plasmo-
dium berghei yoelii (iO parasites/mouse). Horizontal lines in
each graph represent mean 2 SD values of uninfected control
mice.
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samples being in excess of normal. Seven of these
were samples collected between days 35 and 50
(Fig. 2). This increase of urinary protein at the latter
stage of infection may represent the nonserum pro-
tein observed by Weise et a! [23] 38 days after infec-
tion. In Plasmodium berghei berghei-infected mice,
Boonpucknavig, Boonpucknavig, and Bhamarapra-
vati [18] showed that there was a significantly in-
creased total proteinuria from 2.8 mg per 24 hours
at 7, 14, and 21 days following infection. Poels et a!
[22] also reported albuminuria of + to + + +, detect-
ed with a paper strip test, between days 8 to 14 fol-
lowing infection, as did Boonpucknavig et at [18].
Weise, Ehrich, and Weise [23] showed increased al-
bumin excretion by microdisc electrophoresis in
their mice infected with Plasmodium berghei yoelii.
We thought it worthwhile to investigate total albu-
min excretion (Fig. 2). The 24-hour excretion of al-
bumin in controls was 0.26 0.20mg (mean 2 SD)
in 37 samples. In the infrcted mice, a number of
samples showed increased albuminuria between
day 5 and 8 (38% of samples collected at this time
were abnormal, mean 0.47 0.08 per 24 hours,
SEM). At all other points, the albumin excretion was
normal. Weise et a! [39] also noted this very tran-
sient albuminuria on day 8 following infection.
Serum complement estimations were made in the
ICI-SAS mice [21]. There was a fall 7 days after in-
fection to 60% of normal, with a slow decline to just
below 50% of normal at 32 days following infection.
After this, C3 levels gradually returned to normal.
Poels et al [22] assessed C4 semiquantitatively and
found reduced precipitation lines in the acute dis-
ease. It is not clear whether this fall in complement
results from complement activation by immune
complexes, or by direct complement activation by
plasmodial products.
Immune complex deposition in kidneys. Frozen
sections from 30 uninfected CD-i mice aged 6, 8,
and 30 weeks were examined. Like the ICI-SAS,
TO, A2G, and LACA contrOl mice examined pre-
viously [21], only one mouse showed weak segmen-
tal glomerular deposition of Ig and C3. In contrast
to the statements that all mice show immune com-
plex deposits normally [40], none of the uninfected
mice of the different strains we examined with a
sensitive method for immunofluorescence [21]
showed deposits in the glomeruli.
The timing of appearance of immune deposits in
the CD-l mice is shown in Table 2. In general, the
kidneys became positive at around day 7, with only
1 of 14 sections being positive between day 3 and
day 6. From day 7 to day 9, half were positive for
Table 2. Intrarenal complement and immunoglobulin depositsa
No.of No.of
No. of mice mice
Days from mice positive positive
infection studied for Ig for C3
Uninfected 30 1(0) 1(0)
3to6 14 2(0) 1(0)
7to9 39 25(1) 20(2)
10 to 35 37 37(33) 37(36)
42to70 17 8(2) 8(3)
a Numbers in parenthesis show numbers of mice with intense
fluorescence (++/+++).
C3 and Ig, and from day 10 to day 35 all but 2
showed strong immunofluorescence (35 + + 1++ +
and 2 +) for both Ig and C3 of the 17 sections stud-
ied between days 42 and 70; 9 (53%) were negative
for both C3 and 1g. Only 2 were strongly positive
(++) for C3, and 3 were strongly positive for 1g.
The distribution was usually mesangial with some
peripheral material apparently it the capillary wall
(Fig. 3). The deposits contained IgG1, 1gM, and C3;
IgA was absent [21], although Poels et al [22] found
this class to be present.
The timing of the immune complex deposition in
the kidneys has been almost identical in most of the
reported studies [17—19, 21, 22]. Suzuki [20] did not
observe deposits in any of the infected, but un-
treated, mice studied on days 3 and 6. The un-
treated animals were not studied after this. The
treated mice showed deposits as early as day 5 fol-
lowing infection. In all other studies, the appear-
ance of immune complex deposition in glomeruli
coincides with the appearance of free antibodies in
the circulation, although parasitized red cells are
visible in the circulation from day 1 to 3. It is pos-
sible that antibodies are present earlier, but are all
bound by parasites, or free plasmodial antigens.
Poels et al [22] showed that the appearance of free
antibodies correlated with the appearance of immu-
nofluorescent deposits in the kidney; nude mice
produced no antibodies and deposited no com-
plexes. We [21] demonstrated in 1CI-SAS mice that
early treatment with chloroquine or pyrimethamine
to eliminate the antigen load, or later treatment
when the dose of parasites was reduced from l0 to
10, protected against deposition of complexes in
the kidney; thus, this demonstrated the requirement
for the antigen. Contrary to this observation, Su-
zuki [20] showed that even in the presence of high
parasitemia (35% at day 6), the untreated mice did
not show any complexes or antigen in their glomer-
uli. The treated mice were, however, positive for
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Fig. 3. Fluorescent evidence of Ig deposition in the glomerulus of a CD-I mouse killed 13 days after infection with
Plasmodium berghei yoelii. The immunofluorescent deposits are predominantly mesangial with occasional periph-
eral deposits (magnification, x865).
both complement and 1gM deposits despite having a
very low or nil parasitemia.
The results with regard to persistence of immuno-
fluorescence vary, and are perhaps strain-depen-
dent for both the host and the parasite. Ehrich and
Voller [17] noted that deposits disappeared by day
42, but they worked with a model showing a low
early parasitemia (Table 1). Both we [21] in the ICI-
SAS, A2G, and TO mice infected with Plasmodium
berghei yoelii and Poels et al [22] in 14-day-treated
BALB/C mice infected with Plasmodium berghei
found that immunofluorescent deposits persisted
for 70 to 150 days following infection. Despite the
high parasitemia in CD-i mice, more than 50% (9
out of 17) of mice had become negative for immune
complex deposits in the kidneys from day 42 to day
70 following infection. Both Boonpucknavig [18]
and we [21] were able to demonstrate malarial anti-
gens and antimalarial antibodies in the kidneys of
mice at the peak of the infection; and in view of the
suggestion that these persisting deposits may con-
tain antibodies and antigens not directly related to
the plasmodium [22], similar studies on kidneys late
in the infection, from models which show persisting
deposits, would be informative.
Morphology. Optical and electron microscopic
studies on the kidneys of mice infected with both
Plas,nodium berghei berghei [19, 20, 22] and
Plasmodium berghei yoelii [18, 21] have been re-
ported. In general, the changes have been remark-
ably similar in the different studies. No change is
noted in kidneys from mice killed within 3 or 4 days
following infection except for parasitized red cells
in the capillary lumen. From day 7, a number of al-
terations can be seen (Figs. 4 to 8). On optical mi-
croscopy and low power electron microscopy, a
mild mesangial proliferation is seen. Evidence of
deposited material is found principally in the mes-
angial and paramesangial areas (Figs. 4 and 6), but
quite frequent subepithelial aggregates are seen also
(Figs. 7 and 8). Some deposits appear to have the
same electron density as the basement membrane,
and the foot processes of the podocytes are not
fused over them. Many, however, have an appear-
ance closely resembling subepithelial immune de-
posits or "humps" including material that is more
electron-dense than the basement membrane is, and
fusion of epithelial cell foot processes over the area
(Figs. 7 and 8). Subendothelial deposits may be
seen but are uncommon (more frequent is a loosely
4 
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Fig. 4. Electron micrograph showing typical glo,nerular changes due to Plasmodium berghei yoelii infection in CD-i
mice. The mouse was killed 16 days after infection. Note parasitized red cell within the capillary lumen (P-RBC) and
paramesangial and mesangial deposits (—*) (magnification, x 6380).
aggregated material in the subendothelial region,
which is often less electron-dense than the base-
ment membrane is [21]), but they may contain dark-
er material consistent in appearance with fibrin.
Polymorphs (Fig. 6b), platelets, and monocytes
(Fig. 5) may be seen within the capillary lumen,
which is further occluded by swollen endothelial
cells.
The pathogenic changes were still prominent as
late as day 70; subepithelial "knobs" or "humps"
and mesangial and paramesangial deposits still
could be found. The endothelial cells were still
grossly abnormal, and an endothelial microvillous
network was prominent in the capillary lumen (Fig.
8). Weise et a! [24] also observed that the changes
persisted even after the immunofluorescent findings
had reverted to normal.
Results of treatment. Previous reports did not at-
tempt to modify the disease by treatment. In ICI-
SAS mice, we [21] attempted to inhibit the deposi-
tion of complexes with immunosuppressant, anti-
inflammatory, and corticosteroid drugs, but without
effect. Treatment with antiplatelet agents in CD-i
mice did show some effect; 35 mice given sulfin-
pyrazone (0.25 mg/mouse per 24 hours) showed sig-
nificantly less immune complex deposition, as
judged by blind assessment of immunofluorescent
deposits of C3 and Ig, when compared with 36 con-
trol mice. There was, however, no difference in al-
bumin excretion in these animals. Further studies
with larger dose of sulfinpyrazone are in progress.
Discussion
The suggestion that mice infected with Plasma-
dium berghei develop an immune-complex-mediat-
ed glomerulonephritis in the course of the early in-
fection is now strongly supported. Several ques-
tions, however, remain unanswered. The first
relates to the role of the antibody, which leads to
the immune complexes, in the defense of the host
against the parasite. Clark and Allison [41], Brown,
Allison, and Taylor [42], and others [43, 44] have
produced evidence suggesting that the main early
defense of the host is thymus-dependent. Wein-
baum et al [45] were able to show, however, that, as
well as intact T-cell function, B-cell activity was
necessary for elimination of Plasmodiu,n berghei
voelii in BALB/C mice. The demonstration of
plasmodial antigen in the glomerular immune de-
posits [18, 20, 21] suggests that at least part of the
i'
i;
9
Plas,n odium infection and nephritis 59
Fig. S. Electron micrograph showing a monoc te, within the capillary lumen of a glomerulus, about to engulf a para-
sitized red cell. The mouse was killed 16 days after infection (magnification, x 14,450).
immune deposit consist of plasmodial-anti-
plasmodial immune complexes. This is confirmed
by the elution of specific antiplasmodial antibody
from the glomeruli [18, 21].
The possibility of nonmalarial" immune com-
plexes participating in the glomerulopathy at the lat-
ter stage of infection is suggested by Poels et al [22].
They failed to show any soluble plasmodial antigen
in the glomeruli of "hyperimmune" mice at day 70,
despite the presence of immune complexes in the
glomeruli and the plasmodial antibodies in the cir-
culation. Passive transfer of plasma from the "hy-
perimmune" mice produced complex deposition in
the kidneys of uninfected control recipients, and in
the kidneys of infected nude mice (which were oth-
erwise negative in fluorescence studies). The unin-
fected recipients' glomeruli remained negative for
soluble antigens, whereas the infected nude recipi-
ents were positive. Thus, there is evidence suggest-
ing that at least a proportion of the complexes in
glomeruli may not relate directly to plasmodium it-
self, or to specific antiplasmodial antibodies. This is
further strengthened by the fact that in mice, as in
other species, including man, immunodepression is
a feature of plasmodial infections [46]. Steward and
Voller [47] showed that the affinity of antibodies
produced by mice infected with Plasmodium ber-
ghei voelii was lower than was that of control mice
which normally produced high-affinity antibodies.
T-cell function also is depressed [46]. The course of
salmonella infection [48] and trypanosomiasis [49,
50] is made more malignant by concomitant infec-
tion with Plasmodiu,n berghei. The possibility
arises, therefore, that some infection facilitated by
the malaria is responsible for the immune com-
plexes.
Another possibility is that the glomerular depos-
its contain autologous antigens and antibodies
against it. Autoimmune phenomena such as anti-
globulins, antinuclear antibodies, and heterophile
agglutinins are a feature of plasmodial infections in
several species [51, 52], and the greatly increased
IgG and 1gM concentrations in malarial individuals
are only in part antiplasmodial antibodies [53]. A
component of normal serum has been suggested as
being the main antigen in the nephritis associated
with Plasmodium gallinaceurn infections in chick-
ens [14]. Antiglobulin complexes also may be pres-
ent, although in the only study in mice which at-
tempted to detect these [22], the results were nega-
tive.
Although there is great variation in mortality be-
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Fig. 6. Electron micrographs showing mesangial and paramesangial deposits (—p). Also note the fused foot processes (*)
and a polymorph (PMN) in panel b. The mouse was killed 16 days after infection (magnification a, x 14,450; b, x 12,750).
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Fig. 7. Electron micrograph showing 'hump-like' deposits (D),
some containing material more electron-dense than the base-
ment membrane. Note the foot processes fused immediately
above the deposits (panel a). (Magnification a. x 30,080; b, x
18,100.)
tween strains with both Plasmodium berghei her-
ghei and Plasmodiurn berghei yoelii, the survivors
seem, almost without exception, to develop glomer-
ulonephntis during the second week following in-
fection. This is true of strains which have been
shown to produce both high- and low-affinity anti-
bodies to protein antigens [21]. The immune depos-
its have been shown to persist at least up to day 70
[22] and even as late as day 150 [21] following infec-
tion. Ehrich and Voller [17] in the TO strain, how-
ever, found that immunofluorescent evidence of
glomerular deposits was absent later than 42 days
following infection. More than half (53%) of our
CD-l mice were also negative for immune complex
deposits in glomeruli from 42 to 70 days following
infection (Table 2).
At a clinical level, the disease was mild in all
strains tested with Plasmodium berghei yoelii. A
transient rise in plasma creatinine, transient albu-
minuria, and an increase of proteinuria in some mice
at a later stage of infection was all that was found
(Fig. 2). Microscopic hematuria was observed in
ICI-SAS mice (we did not test the CD-l mice for the
presence of hematuna). The glomerular abnormal-
ities on optical, electron, and immunofluorescent
microscopy were principally in the mesangium,
with only some glandular deposits at a subepithelial
Fig. 8. Electron micrograph showing subepithelial "hump-like" deposits (D), some containing material more electron-
dense than the basement membrane. Note the endothelial microvillous network within the capillary lumen. The mouse
was killed 70 days after infection (magnification, x 17,850).
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(or rarely subendothelial) site on the peripheral cap-
illary wall. Like most forms of glomerulonephritis
involving only the mesangium in man [54], the prog-
nosis for this lesion appears to be good; although
very long term studies for a year or two following
infection have not been made. With Plasmodium
berghei in the treated BALB/C mice, Poels et al [22]
found that proteinuria was more persistent, still
present at + + + on day 21 following infection. They
also showed that the amount of immunoglobulin de-
posited in the glomeruli did not correlate with the
degree of glomerulonephritis, since animals treated
with chloroquine from day 14 to 21 still showed
heavy immunoglobulin deposition and complement
at day 70 following infection but had no proteinuria,
at least from day 42 onwards (the urine was not test-
ed earlier). Similarly, in our ICI-SAS mice [21], and
some CD-i mice, glomerular deposits of immuno-
globulins and complement persisted long after the
mild urinary abnormalities found in these strains
had subsided.
The mediation of injury in the plasmodial-infect-
ed mouse has not been studied. The presence of
complement components, polymorphonuclear leu-
cocytes, monocytes, and platelets in the glomeruli
of affected mice suggest that mechanisms similar to
those studied in the rabbit [55-58] may operate in
this model, but the experiments to test this hypothe-
sis have yet to be performed.
It thus appears that in unmodified recipient mice,
Plasmodium berghei of at least two strains induces
a mild, predominantly mesangial glomerulonephri-
tis. The analogies with human plasmodial glomeru-
lonephritis are thus much stronger, with the rather
transient acute glomerulonephritis seen in Plasmo-
dium falciparum malaria [59, 60] (Boonpucknavig,
this issue), rather than with the chronic, insidious
nephritis leading to a nephrotic syndrome and ure-
mia described in association with Plasmodium
malariae [2—5].
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